Neurologic infectious disease emergencies

Neurologic Clinics

Volumn 30, Issue 1, 2012, Pages 129-159

  Pruitt, Amy A ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Bacterial meningitis; Central nervous system infections; Encephalitis; Neurologic infectious diseases

Indexed keywords

ACICLOVIR; AMPICILLIN; ANTIBIOTIC AGENT; CEFEPIME; CEFOTAXIME; CEFTAZIDIME; CEFTRIAXONE; CHLORAMPHENICOL; CIPROFLOXACIN; CORTICOSTEROID; DEXAMETHASONE; DOXYCYCLINE; ETHAMBUTOL; FAMCICLOVIR; GENTAMICIN; IMMUNOSUPPRESSIVE AGENT; ISONIAZID; LINEZOLID; MEROPENEM; METRONIDAZOLE; MOXIFLOXACIN; PLECONARIL; PYRAZINAMIDE; PYRIDOXINE; RIFAMPICIN; RITUXIMAB; TRIMETHOPRIM; UNINDEXED DRUG; VALACICLOVIR; VANCOMYCIN;

ANTIMICROBIAL THERAPY; ANTIVIRAL THERAPY; BACTERIAL ENDOCARDITIS; BACTERIAL MENINGITIS; BRAIN ABSCESS; CENTRAL NERVOUS SYSTEM INFECTION; CEREBROSPINAL FLUID EXAMINATION; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CRYPTOCOCCAL MENINGITIS; CYSTICERCOSIS; DIFFERENTIAL DIAGNOSIS; DIFFUSION WEIGHTED IMAGING; ENTEROVIRUS 71; EPSTEIN BARR VIRUS; FACIAL NERVE PARALYSIS; GLASGOW COMA SCALE; HERPES SIMPLEX ENCEPHALITIS; HERPES ZOSTER ENCEPHALITIS; HOST PATHOGEN INTERACTION; HUMAN; HYDROCEPHALUS; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; INFECTION; INFECTION RISK; INFLUENZA VIRUS; LUMBAR PUNCTURE; LYME DISEASE; MENINGOENCEPHALITIS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MORBIDITY; MORTALITY; NEUROCYSTICERCOSIS; NEUROIMAGING; NEUROLEPTIC INDUCED DEFICIT SYNDROME; NEUROLOGIC DISEASE; NEUROLOGIC EXAMINATION; NEUROLOGIC INFECTIOUS DISEASE; NEUROSYPHILIS; NUCLEAR MAGNETIC RESONANCE IMAGING; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; PYOMYOSITIS; REVIEW; SERODIAGNOSIS; SPINAL CORD INFECTION; TICK BORNE DISEASE; TOXOPLASMA GONDII; TUBERCULOSIS; TUBERCULOUS MENINGITIS; VACCINATION; VARICELLA ZOSTER VIRUS; VIRUS ENCEPHALITIS; VIRUS MENINGITIS; WEST NILE FLAVIVIRUS; EMERGENCY;

CENTRAL NERVOUS SYSTEM INFECTIONS; EMERGENCIES; HUMANS;

EID: 84856256428     PISSN: 07338619     EISSN: 15579875     Source Type: Journal    
DOI: 10.1016/j.ncl.2011.09.011     Document Type: Review

References (112)

1. Tan K., Patel S., Gandhi N., et al. Burden of neuroinfectious diseases on the neurology service in a tertiary care center. Neurology 2008, 71:1160-1166.
2. Ziai W.C., Lewin J.J. Update in the diagnosis and management of central nervous system infections. Neurol Clin 2008, 26:427-468.
3. Roos K., Tyler K.L. Meningitis, encephalitis, brain abscess and empyema. Harrison's neurology in clinical medicine 2010, 451-483. McGraw-Hill, New York. 2nd edition. S.L. Hauser, S.A. Josephson (Eds.).
4. Honda H., Warren D.K. Central nervous system infections: meningitis and brain abscess. Infect Dis Clin North Am 2009, 23:609-623.
5. Mace S.E. CNS infections as a cause of an altered mental status? What is the pathogen growing in your CNS?. Emerg Med Clin North Am 2010, 28:535-570.
6. Fitch M.T., Abrahamian F.M., Moran G.J., et al. Emergency department management of meningitis and encephalitis. Infect Dis Clin North Am 2008, 22:33-52.
7. Rincon F., Badjatia N. CNS infections in the neurointensive care unit. Curr Treat Options Neurol 2006, 8:135-144.
8. Hasbun R., Abrahams J., Jekel J., et al. Computed tomography of the head before lumbar puncture in adults with suspected meningitis. NEngl J Med 2001, 345:1727-1733.
9. Van de Beek D., de Gans J., Spanjaard L., et al. Clinical features and prognostic factors in adults with bacterial meningitis. NEngl J Med 2004, 351:1849-1859.
10. Durand M.L., Calderwood S.B., Weber D.J., et al. Acute bacterial meningitis in adults. A review of 493 episodes. NEngl J Med 1993, 328:21-28.
11. Brivet F.G., Ducuing S., Jacobs F., et al. Accuracy of clinical presentation for differentiating bacterial from viral meningitis in adults: a multivariate approach. Intensive Care Med 2005, 31:1654-1660.
12. Safdieh J.E., Mead P.A., Sepkowitz A., et al. Bacterial and fungal meningitis in patients with cancer. Neurology 2008, 70:943-947.
13. Cabellos C., Verdquer R., Olmo M., et al. Community-acquired bacterial meningitis in elderly patients: experience over 30 years. Medicine 2009, 88:115-119.
14. Kourbeti I.S., Jacobs A.V., Koslow M., et al. Risk factors associated with postcraniotomy meningitis. Neurosurgery 2007, 60:317-325.
15. Pizon A.F., Bonner M.R., Want H.E., et al. Ten years of clinical experience with adult meningitis at an urban academic medical center. JEmerg Med 2006, 30:367-370.
16. Walker M., Zunt J.R. Parasitic CNS infections in immunocompromised hosts. Clin Infect Dis 2005, 40:1005-1015.
17. Saiz A., Graus F. Neurologic complications of hematopoietic cell transplantation. Semin Neurol 2010, 30:287-295.
18. Rosenfeld M.R., Pruitt A.A. Neurologic complications of bone marrow, stem cell, and organ transplantation in patients with cancer. Semin Oncol 2006, 33:352-361.
19. Pruitt A.A. Central nervous system infections in cancer patients. Semin Neurol 2010, 30:296-310.
20. Van de Beek D., de Gans J., McIntyre P., et al. Corticosteroids for acute bacterial meningitis. Cochrane Database Syst Rev 2007, 1. CD004405.
21. Van de Beek D., Farrar J.J., de Gans J., et al. Adjunctive dexamethasone in bacterial meningitis: a meta-analysis of individual patient data. Lancet Neurol 2010, 9:254-263.
22. Tunkel A.R., Hartman B.J., Kaplan S.L., et al. Practice guidelines for the management of bacterial meningitis. Clin Infect Dis 2004, 39:1267-1284.
23. Nudelman Y., Tunkel A.R. Bacterial meningitis: epidemiology, pathogenesis and management update. Drugs 2009, 69:2577-2596.
24. Brouwer M.C., Heckenberg S.G., de Gans J., et al. Nationwide implementation of adjunctive dexamethasone therapy for pneumococccal meningitis. Neurology 2010, 75:1533-1539.
25. Ricard J.D., Wolff M., Lacherade J.C., et al. Levels of vancomycin in CSF of adult patients receiving adjunctive corticosteroids to treat pneumococcal meningitis: a prospective multicenter observational study. Clin Infect Dis 2007, 44:250-255.
26. Kamei S., Seikizawa T., Shiota H., et al. Evaluation of combination therapy using acyclovir and corticosteroids in adult patients with HSV encephalitis. JNeurol Neurosurg Psychiatry 2005, 76:1544-1549.
27. Abba K., Ramaratnam S., Ranganathan L.N. Antihelmintics for people with neurocysticercosis. Cochrane Database Syst Rev 2010, 3. CD000215.
28. Thwaites G.E., Nguyen D.B., Nguyen H.D., et al. Dexamethasone for the treatment of tuberculous meningitis in adolescents and adults. NEngl J Med 2004, 351:1741-1751.
29. Sinner S.W. Approach to the diagnosis and management of tuberculous meningitis. Curr Infect Dis Rep 2010, 12:291-298.
30. Prasad K., Singh M.B. Corticosteroids for managing tuberculous meningitis. Cochrane Database Syst Rev 2008, 1. CD002244.
31. Chapman A.S., Bakken J.S., Folk S.M., et al. Diagnosis and management of tick-borne rickettsial diseases: rocky mountain spotted fever, ehrlichioses, and anaplasmosis-United States: a practical guide for physicians and other health-care and public health professionals. MMWR Recomm Rep 2006, 55(RR-4):1-27.
32. Cahill D.P., Barker F.G., Davis K.R., et al. Case 10-2010: a 37-year-old woman with weakness and a mass in the brain. Case records MGH. NEngl J Med 2010, 362:1326-1333.
33. Kastrup O., Wanke I., Maschke M. Neuroimaging of infections of the central nervous system. Semin Neurol 2008, 28:511-522.
34. Ben Salem D., Peruse de Montclos E., Couaillier J.F., et al. Urgences neuroradiologiques en pathologie infectieuse. JNeuroradiol 2004, 31:301-312.
35. Hong J.T., Son B.C., Sun J.H., et al. Significance of diffusion-weighted imaging and apparent diffusion coefficient maps for the evaluation of pyogenic ventriculitis. Clin Neurol Neurosurg 2008, 110:137-144.
36. Van Gastel E., Bruynseels P., Verstrepen W., et al. Evaluation of a real-time PCR assay for the diagnosis of pneumococcal and meningococcal meningitis in a tertiary care hospital. Eur J Clin Microbiol Infect Dis 2007, 26:651-653.
37. Rothman R., Ramachandran P., Yang S., et al. Use of quantitative broad-based polymerase chain reaction for detection and identification of common bacterial pathogens in cerebrospinal fluid. Acad Emerg Med 2010, 17:741-747.
38. Hedberg S.T., Olcen P., Fredlung H., et al. Real-time PCR detection of five prevalent bacteria causing acute meningitis. APMIS 2009, 117:856-860.
39. Taha M.K., Vazquez J.A., Hong E., et al. Target gene sequencing to characterize the penicillin G susceptibility of Neisseria meningitides. Antimicrobial Agents Chemother 2007, 51:2784-2792.
40. Chen S.C., Kontoyiannis D.P. New molecular and surrogate biomarker-based tests in the diagnosis of bacterial and fungal infection in febrile neutropenic patients. Curr Opin Infect Dis 2010, 23:567-577.
41. Kasanmoentalib E.S., Brouwer M.C., Van der Ende A., et al. Hydrocephalus in adults with community acquired bacterial meningitis. Neurology 2010, 75:918-923.
42. Carrera E., Claassen J., Oddo M.L., et al. Continuous electroencephalographic monitoring of critically ill patients with CNS infections. Arch Neurol 2008, 65:1612-1618.
43. Kost C.B., Rogers B., Oberste S., et al. Multicenter beta trial of the GeneXpert enterovirus assay. JClin Microbiol 2007, 45:1081-1086.
44. Granerod J., Cunningham R., Zuckerman M., et al. Causality in acute encephalitis: defining aetiologies. Epidemiol Infect 2010, 138:783-800.
45. Granerod J., Tam C.C., Crowcroft N.S., et al. Challenge of the unknown: a systematic review of acute encephalitis in non-outbreak situations. Neurology 2010, 75:924-932.
46. Tunkel A.R., Glaser C.A., Bloch K.C., Infectious Diseases Society of America, et al. The management of encephalitis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis 2008, 47:303-327.
47. Seeley W.W., Marth F.M., Holmes T.M., et al. Post-transplant acute limbic encephalitis. Neurology 2007, 69:156-165.
48. Vincent A., Buckley C., Schott J.M., et al. Potassium channel antibody-associated encephalopathy: a potentially immunotherapy-responsive form of limbic encephalitis. Brain 2004, 127(pt 3):701-712.
49. Prüss H., Dalmau J., Harms L., et al. Retrospective analysis of NMDA receptor antibodies in encephalitis of unknown origin. Neurology 2010, 75:1735-1739.
50. Gable M.S., Gaval S., Radner A., et al. Anti-NMDA receptor encephalitis: report of ten cases and comparison with viral encephalitis. Eur J Clin Microbiol Infect Dis 2009, 28:1421-1429.
51. Glaser C.A., Honarmand S., Anderson L., et al. Beyond viruses: clinical profiles and etiologies associated with encephalitis. Clin Infect Dis 2006, 43:1565-1577.
52. Florance N.R., Davis R.L., Lam C., et al. Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis in children and adolescents. Ann Neurol 2009, 66:11-18.
53. Petersen L.R., Hayes E.B. West Nile virus in the Americas. Med Clin North Am 2008, 92:1307-1322.
54. Reznicek J.E., Mason W.J., Kaul D.R., et al. Avoiding a rash diagnosis. NEngl J Med 2011, 364:466-471.
55. Davis L.E., DeBiasi R., Goade D.E., et al. West Nile virus neuroinvasive disease. Ann Neurol 2006, 60:286-300.
56. Solomon T., Hart I.J., Beeching N.J. Viral encephalitis: a clinician's guide. Pract Neurol 2007, 7:288-305.
57. Tyler K.L. Emerging viral infections of the CNS parts I and II. Arch Neurol 2009, 66:939-948. 1065-74.
58. Desmond R.A., Accortt N.A., Talley L., et al. Enteroviral meningitis: natural history and outcome of pleconaril therapy. Antimicrobial Agents Chemother 2006, 50:2409-2414.
59. Ganjoo K.N., Raman R., Sobel R.A., et al. Opportunistic enteroviral meningoencephalitis: an unusual treatable complication of rituximab therapy. Leuk Lymphoma 2009, 50:673-675.
60. Halperin J.J., Shapiro E.D., Logigian E.L., et al. Practice parameter: treatment of nervous system Lyme disease. Neurology 2007, 69:91-102.
61. Halperin J.J. Nervous system Lyme disease. JR Coll Physicians Edinb 2010, 40(3):248-255.
62. Blanc F., Jaulhac B., Fleury M., et al. Relevance of the antibody index to diagnose Lyme neuroborreliosis among seropositive patients. Neurology 2007, 69:953-958.
63. Lantos P.M., Charini W.A., Medoff G., et al. Final report of the Lyme disease review panel of the Infectious Diseases Society of America. Clin Infect Dis 2010, 51:1-5.
64. Wormser G.P., Dattwyler R.J., Shapiro E.D., et al. The clinical assessment, treatment, and prevention of Lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis 2006, 41:1089-1134.
65. Fallon B.A., Keilp J.G., Corbera K.M., et al. Arandomized, placebo-controlled trial of repeated IV antibiotic therapy for Lyme encephalopathy. Neurology 2008, 70:992-1003.
66. Feder H.M., Johnson B.J., O'Connell S., et al. Acritical appraisal of chronic Lyme disease. NEngl J Med 2007, 357:422-430.
67. Gleeson T., Etienne M. Cranial nerve VII palsy as the first sign of cephalic tetanus after an earthquake. Arch Neurol 2011, 68:536-537.
68. Yis U., Kurul S.H., Cakmakci H., et al. Mycoplasma pneumoniae: nervous system complications in childhood and review of the literature. Eur J Pediatr 2008, 167:973-978.
69. Schmidt C., Plate A., Angele B., et al. Aprospective study on the role of CXCL13 in Lyme neuroborreliosis. Neurology 2011, 76:1051-1058. Accompanying editorial: Tuman H, David D. Are high CSF levels of CXCL 13 helpful for diagnosis of Lyme neuroborreliosis? Neurology 2011;76:1036-7.
70. Pless M.L., Korshinsky D., LaRocque R.C., et al. Case records of the MGH. Case 26-2010: a 54-year-old man with loss of vision and a rash. NEngl J Med 2010, 363:865-874.
71. Kiss S., Damico F.M., Young L.H. Ocular manifestations and treatment of syphilis. Semin Ophthalmol 2005, 20:161-167.
72. Marra C.M. Update on neurosyphilis. Curr Infect Dis Rep 2009, 11:127-134.
73. Ghanem K.G., Moore R.D., Rompalo A.M., et al. Neurosyphilis in a clinical cohort of HIV-1-infected patients. AIDS 2008, 22:1145-1151.
74. Bestard J., Siddiqi Z.A. Cryptococcal meningoencephalitis in immunocompetent patients: changing trends in Canada. Neurology 2010, 74:1233-1234.
75. Airas L., Paivarinta M., Roytta M., et al. Central nervous system immune reconstitution inflammatory syndrome (IRIS) after hematopoietic stem cell transplantation. Bone Marrow Transplant 2009, 34:1-4.
76. Granwehr B.P., Lillibridge K.M., Higgs S., et al. West nile virus: where are we now?. Lancet Infect Dis 2004, 4:547-556.
77. Ooi M.H., Wong S.C., Pidin Y., et al. Human enterovirus 71 disease in Sarawak, Malaysia: a prospective clinical, virological and molecular epidemiological study. Clin Infect Dis 2007, 44:646-656.
78. Ekstrand J.J., Herener A., Rawlings J., et al. Heightened neurologic complications in children with pandemic H1N1 influenza. Ann Neurol 2010, 68:762-766.
79. Kedia S., Stroud B., Parsons J., et al. Pediatric neurological complications of 2009 pandemic influenza A (H1N1). Arch Neurol 2011, 68:455-462.
80. Augarten A., Aderka D. Alice in wonderland syndrome in H1N1 influenza. Pediatr Emerg Care 2011, 27:120.
81. Nagel M.A., Gilden D.H. The protean neurologic manifestations of varicella-zoster virus infection. Cleve Clin J Med 2007, 74:489-494.
82. Nagel M.A., Cohrs R.J., Mahalingam R., et al. The varicella zoster virus vasculopathies: clinical, CSF, imaging and virologic features. Neurology 2008, 70:853-860.
83. Gilden D., Cohrs R.J., Mahalingam R., et al. Varicella zoster virus vasculopathies: diverse clinical manifestations, laboratory features, pathogenesis, and treatment. Lancet Neurol 2009, 8:731-740.
84. Nakamoto B.K., Dorotheo E.U., Biousse V., et al. Progressive outer retinal necrosis presenting with isolated optic neuropathy. Neurology 2004, 63:2423-2425.
85. Salazar R., Russman A.N., Nagel M.A., et al. Varicella zoster virus ischemic optic neuropathy and subclinical temporal artery involvement. Arch Neurol 2011, 68:517-520.
86. Ahmad I., Cau N.V., Kwan J., et al. Preemptive management of Epstein-Barr virus reactivation after hematopoietic stem-cell transplantation. Transplantation 2009, 8:140-145.
87. Fugate J.F., Claasen D.O., Cloft H.J. Posterior reversible encephalopathy syndrome: associated clinical and radiologic findings. Mayo Clin Proc 2010, 85:427-432.
88. Aksamit A.J. Progressive multifocal leukoencephalopathy. Curr Treat Options Neurol 2008, 10:178-185.
89. Carson K.B., Evens A.M., Richey E.A., et al. Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports project. Blood 2009, 113:4834-4840.
90. Gheuens S., Pierone G., Peeters P., et al. Progressive multifocal leukoencephalopathy in individuals with minimal or occult immunosuppression. JNeurol Neurosurg Psychiatr 2010, 81:247-254.
91. Brickelmaiaer M., Lugovskoy A., Kartikeyan R., et al. Identification and characterization of mefloquine efficacy against JC virus invitro. Antimicrobial Agents Chemother 2009, 53:1840-1849.
92. Singh G., Rajshekhar V., Murthy J.M., et al. Adiagnostic and therapeutic scheme for a solitary cysticercus granuloma. Neurology 2010, 75:2236-2245.
93. Bernardini G.L. Diagnosis and management of brain abscess and subdural empyema. Curr Neurol Neurosci Rep 2004, 4:448-456.
94. Tseng J.H., Tseng M.Y. Brain abscess in 142 patients: factors influencing outcome and mortality. Surg Neurol 2006, 65:557-562.
95. Hakan T., Cerana N., Erdem I., et al. Bacterial brain abscesses: an evaluation of 96 cases. JInfect 2006, 52:359-366.
96. Osborn M.K., Steinberg J.P. Subdural empyema and other suppurative complications of paranasal sinusitis. Lancet Infect Dis 2007, 7:662-667.
97. Cabell C.H., Jollis J.G., Peterson G.E., et al. Changing patient characteristics and the effect on mortality in endocarditis. Arch Intern Med 2002, 162:90-94.
98. Murdoch D.R., Corey G.R., Hoen B., et al. Clinical presentation, etiology and outcome of infective endocarditis in the 21st century. Arch Intern Med 2009, 169:463-473.
99. Pruitt A.A., Rubin R.H., Karchmer A.W., et al. Neurological complications of bacterial endocarditis. Medicine (Baltimore) 1978, 57:329-343.
100. Duval X., Lung B., Kelin I., et al. Effect of early clinical MR imaging on clinical decisions in infective endocarditis. Ann Intern Med 2010, 152:497-504.
101. Vikram H.R., Buencosejo J., Hasbun R., et al. Impact of valve surgery on 6-month mortality in adults with complicated, left-sided native valve endocarditis: a propensity analysis. JAMA 2003, 290:3207-3214.
102. Jacob A., Weinshenker B.G. An approach to the diagnosis of acute transverse myelitis. Semin Neurol 2008, 28:105-120.
103. Darouiche R.O. Spinal epidural abscess. NEngl J Med 2006, 355:2012-2020.
104. Pradilla G., Nagahama Y., Spivak A.M., et al. Spinal epidural abscess: current diagnosis and management. Curr Infect Dis Rep 2010, 12:484-491.
105. Sendi P., Bregenzer T., Zimmerli W. Spinal epidural abscess in clinical practice. QJM 2008, 101:1-12.
106. Reihsaus E., Waldbaur H., Seeling W. Spinal epidural abscess: a meta-analysis of 915 patients. Neurosurg Rev 2000, 23:175-204.
107. Pradilla G., Ardila G.P., Hsu W., et al. Epidural abscesses of the CNS. Lancet Neurol 2009, 8:292-300.
108. Moellering R.C., Abbott G.F., Ferraro M.J. Case Records of the MGH. Case 2-2011: a 30-year-old woman with shock after treatment of a furuncle. NEngl J Med 2011, 364:266-275.
109. Moellering R.C. The growing menace of community-acquired methicillin-resistant Staphylococcus aureus. Ann Intern Med 2006, 144:368-370.
110. Wisplinghoff H., Bischoff T., Tallent S.M., et al. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis 2004, 39:309-317.
111. Vigil K.J., Johnson J.R., Johnston B.D., et al. E coli pyomyositis: an emerging infectious disease among patients with hematologic malignancies. Clin Infect Dis 2010, 50:374-380.
112. Crum N.F. Bacterial pyomyositis in the United States. Am J Med 2004, 117:420-428.